The decreased levels of NPTXR allow for differentiation of dementia patients, as well as those with MCI and AD, from controls (p =  0.002 and p =  0.013, respectively) (Table 2), but not between both dementia stages (p =  0.536). The gene discussed is NPTXR; the disease is Alzheimer disease.